BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30149132)

  • 1. Synthesis, screening and docking analysis of novel benzimidazolium compounds as potent anti microbial agents targeting FtsZ protein.
    Sangeeta GPV; Purna Nagasree K; Risy Namratha J; Krishna Kumar MM
    Microb Pathog; 2018 Nov; 124():258-265. PubMed ID: 30149132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodioxane-Benzamides as Antibacterial Agents: Computational and SAR Studies to Evaluate the Influence of the 7-Substitution in FtsZ Interaction.
    Straniero V; Sebastián-Pérez V; Hrast M; Zanotto C; Casiraghi A; Suigo L; Zdovc I; Radaelli A; De Giuli Morghen C; Valoti E
    ChemMedChem; 2020 Jan; 15(2):195-209. PubMed ID: 31750973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and structure-based optimization of novel isoxazole-containing benzamide derivatives as FtsZ modulators.
    Bi F; Song D; Zhang N; Liu Z; Gu X; Hu C; Cai X; Venter H; Ma S
    Eur J Med Chem; 2018 Nov; 159():90-103. PubMed ID: 30268826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtual screening of potential inhibitor against FtsZ protein from Staphylococcus aureus.
    Vijayalakshmi P; Nisha J; Rajalakshmi M
    Interdiscip Sci; 2014 Dec; 6(4):331-9. PubMed ID: 25519150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological activity evaluation of novel 2,6-difluorobenzamide derivatives through FtsZ inhibition.
    Bi F; Guo L; Wang Y; Venter H; Semple SJ; Liu F; Ma S
    Bioorg Med Chem Lett; 2017 Feb; 27(4):958-962. PubMed ID: 28082038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parallel solid synthesis of inhibitors of the essential cell division FtsZ enzyme as a new potential class of antibacterials.
    Paradis-Bleau C; Beaumont M; Sanschagrin F; Voyer N; Levesque RC
    Bioorg Med Chem; 2007 Feb; 15(3):1330-40. PubMed ID: 17157508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catechol-bearing imidazolium and benzimidazolium chlorides as promising antimicrobial agents.
    Karataş MO; Günal S; Mansur A; Alıcı B; Özdemir İ
    Arch Pharm (Weinheim); 2020 Jun; 353(6):e2000013. PubMed ID: 32301169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2/3D-QSAR, molecular docking and MD simulation studies of FtsZ protein targeting benzimidazoles derivatives.
    Ahamad S; Islam A; Ahmad F; Dwivedi N; Hassan MI
    Comput Biol Chem; 2019 Feb; 78():398-413. PubMed ID: 30602415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New antimicrobial compounds produced by endophytic Penicillium janthinellum isolated from Panax notoginseng as potential inhibitors of FtsZ.
    Xie J; Wu YY; Zhang TY; Zhang MY; Peng F; Lin B; Zhang YX
    Fitoterapia; 2018 Nov; 131():35-43. PubMed ID: 30291967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and evaluation of novel 9-arylalkyl-10-methylacridinium derivatives as highly potent FtsZ-targeting antibacterial agents.
    Song D; Zhang N; Zhang P; Zhang N; Chen W; Zhang L; Guo T; Gu X; Ma S
    Eur J Med Chem; 2021 Oct; 221():113480. PubMed ID: 33964649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An endophytic Fungi of Ginkgo biloba L. produces antimicrobial metabolites as potential inhibitors of FtsZ of Staphylococcus aureus.
    Wu YY; Zhang TY; Zhang MY; Cheng J; Zhang YX
    Fitoterapia; 2018 Jul; 128():265-271. PubMed ID: 29864480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, antibacterial activity, synergistic effect, cytotoxicity, docking and molecular dynamics of benzimidazole analogues.
    Srivastava R; Gupta SK; Naaz F; Singh A; Singh VK; Verma R; Singh N; Singh RK
    Comput Biol Chem; 2018 Oct; 76():1-16. PubMed ID: 29857255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Pharmacological Evaluation of Novel Pleuromutilin Derivatives with Substituted Benzimidazole Moieties.
    Ai X; Pu X; Yi Y; Liu Y; Xu S; Liang J; Shang R
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27834819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological screening and molecular modeling studies of novel 3-chloro-4-substituted-1-(2-(1H-benzimidazol-2-yl)phenyl))-azetidin-2-ones.
    Chhajed SS; Upasani CD
    J Enzyme Inhib Med Chem; 2012 Aug; 27(4):504-8. PubMed ID: 21823835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, antimicrobial activity and computational studies of novel azo linked substituted benzimidazole, benzoxazole and benzothiazole derivatives.
    Mishra VR; Ghanavatkar CW; Mali SN; Qureshi SI; Chaudhari HK; Sekar N
    Comput Biol Chem; 2019 Feb; 78():330-337. PubMed ID: 30639681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, in vitro evaluation, and molecular docking studies of azetidinones and thiazolidinones of 2-amino-5-cyclopropyl-1,3,4-thiadiazole as antibacterial agents.
    Patel H; Mishra L; Noolvi M; Karpoormath R; Cameotra SS
    Arch Pharm (Weinheim); 2014 Sep; 347(9):668-84. PubMed ID: 25066774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BT-benzo-29 inhibits bacterial cell proliferation by perturbing FtsZ assembly.
    Ray S; Jindal B; Kunal K; Surolia A; Panda D
    FEBS J; 2015 Oct; 282(20):4015-33. PubMed ID: 26258635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of the cell-division inhibitor PC190723: modulation of FtsZ assembly cooperativity.
    Elsen NL; Lu J; Parthasarathy G; Reid JC; Sharma S; Soisson SM; Lumb KJ
    J Am Chem Soc; 2012 Aug; 134(30):12342-5. PubMed ID: 22793495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Carbocyclic Curcumin Inhibits Proliferation of Gram-Positive Bacteria by Targeting FtsZ.
    Groundwater PW; Narlawar R; Liao VW; Bhattacharya A; Srivastava S; Kunal K; Doddareddy M; Oza PM; Mamidi R; Marrs EC; Perry JD; Hibbs DE; Panda D
    Biochemistry; 2017 Jan; 56(3):514-524. PubMed ID: 28002947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antibacterial activity of novel 4-bromo-1H-indazole derivatives as FtsZ inhibitors.
    Wang Y; Yan M; Ma R; Ma S
    Arch Pharm (Weinheim); 2015 Apr; 348(4):266-74. PubMed ID: 25773717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.